Indication for Therapy | Usual Causative Organisms | Antimicrobial Regimens |
---|---|---|
Patients with high risk cardiac conditions* undergoing the following interventions:
|
Viridans group streptococci, other Streptococcus spp., Staphylococcus spp. | Standard General Prophylaxis† |
amoxicillin 2 g PO x 1 dose 1 hour prior to procedure | ||
β-lactam allergy (non-anaphylaxis): cephalexin 2 g PO x 1 dose 1 hour prior to procedure |
||
β-lactam allergy (anaphylaxis): clindamycin 600 mg PO x 1 dose 1 hour prior to procedure |
||
Unable to take Oral Medications | ||
ampicillin 2 g IV/IM x 1 dose within 30 min before procedure |
||
β-lactam allergy (non-anaphylaxis): ceFAZolin 1 g IV x 1 dose 1 hour prior to procedure |
||
β-lactam allergy (anaphylaxis): vancomycin 15 mg/kg IV once (not to exceed 2 grams) within 120 minutes prior to procedure |
||
Gastrointestinal and genitourinary procedures | Enterococcus spp. | Routine prophylaxis no longer recommended‡ |
* Cardiac conditions associated with highest risk of adverse outcomes from endocarditis:
Prosthetic cardiac valve
Previous infective endocarditis
Congenital heart disease (CHD) with non-repaired cyanotic CHD (including palliative shunts & conduits) or completely repaired congenital heart defect with prosthetic material or device during first 6 months after procedure or repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or device
Cardiac transplant recipients who develop cardiac valvulopathy (i.e. documented substantial leaflet pathology and regurgitation)
† In the event that an antibiotic is inadvertently not given prior to the procedure the dosage may be given up to 2 hours afterwards.
‡ Patients with an established GI/GU infection or enterococcal colonization should receive prophylaxis with amoxicillin/ampicillin or vancomycin (if patient has a penicillin allergy).
Prevention of Infective Endocarditis – Guidelines from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee. Circulation. 2007; 116:1736-1754.